MacuCLEAR MC-1101

MC-1101 · MacuCLEAR, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MacuCLEAR MC-1101, covering 2014-04-30 to 2014-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration [Phase 2, Phase 3]

See pricing